12 Recruiting Studies Using Etoposide Phosphate
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Etoposide Phosphate
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
📍 University of Florida Proton Therapy Institute — Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist ➔Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
Lymphoma
View Study & Checklist ➔Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Adult T-Cell Leukemia/Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
📍 Children's Hospital of Alabama — Birmingham, Alabama
Germ Cell Tumor
View Study & Checklist ➔A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
📍 Children's Hospital of Alabama — Birmingham, Alabama
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
View Study & Checklist ➔Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
📍 Alberta Children's Hospital — Calgary, Alberta
CNS Embryonal Tumor
View Study & Checklist ➔Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
📍 Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois
Medulloblastoma Recurrent
View Study & Checklist ➔Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔